Date Posted: June 11, 2026

Author/s: Camille Patricia T. De Castro, MD; Mari Karr A. Esguerra, MD, MSPH, DHA, FPSP and Florido A. Atibagos Jr., MD, FPSP

This study aimed to review updates on laboratory tests used for diagnosing along with recent developments in diagnosing and managing eumycetoma.

Reported here is a case of a 55-year-old male with a twenty-six-year history of recurrent left plantar mass associated with discharging black granules and pain on ambulation. The patient was unresponsive to antibacterial and antifungal therapy.

Surgical excision of the mass combined with antifungal therapy using Itraconazole 200 mg twice a day was given post-surgery. Currently, the patient is ambulatory with minimal assistance using the cane. The patient undergoes regular follow-ups and is subjected for re-evaluation after 6 months to re-assess the patient’s treatment regimen.

Identification of the microorganism remains to be the cornerstone of treatment. Eumycetoma is frequently neglected and diagnosed at an advanced stage. If left untreated, involvement of underlying tissues such as the bones and muscles could lead to fatal consequences. Therefore, comprehensive clinical examination, using specialized stains, histological and microbiological investigations, and appropriate treatment is recommended to diagnose mycetoma.

Keywords:
mycetoma, eumycetoma, Madura foot